TPO receptor agonist for chronic idiopathic thrombocytopenic purpura.

Abstract

BACKGROUND Chronic idiopathic thrombocytopenic purpura (ITP) is an acquired autoimmune disorder that is characterized predominantly by a low platelet count. Thrombopoietin (TPO) receptor agonists increase production of platelets by stimulating the TPO receptor in people with chronic ITP. OBJECTIVES To determine the efficacy and safety of TPO receptor… (More)
DOI: 10.1002/14651858.CD008235.pub2

Topics

5 Figures and Tables

Slides referencing similar topics